TrialJournal of cancer research and clinical oncology2008

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.

Kimberly B Higginbotham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.